Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data

Otavio T Ranzani, Leonardo S L Bastos, João Gabriel M Gelli, Janaina F Marchesi, Fernanda Baião, Silvio Hamacher, Fernando A Bozza, Otavio T Ranzani, Leonardo S L Bastos, João Gabriel M Gelli, Janaina F Marchesi, Fernanda Baião, Silvio Hamacher, Fernando A Bozza

Abstract

Background: Most low-income and middle-income countries (LMICs) have little or no data integrated into a national surveillance system to identify characteristics or outcomes of COVID-19 hospital admissions and the impact of the COVID-19 pandemic on their national health systems. We aimed to analyse characteristics of patients admitted to hospital with COVID-19 in Brazil, and to examine the impact of COVID-19 on health-care resources and in-hospital mortality.

Methods: We did a retrospective analysis of all patients aged 20 years or older with quantitative RT-PCR (RT-qPCR)-confirmed COVID-19 who were admitted to hospital and registered in SIVEP-Gripe, a nationwide surveillance database in Brazil, between Feb 16 and Aug 15, 2020 (epidemiological weeks 8-33). We also examined the progression of the COVID-19 pandemic across three 4-week periods within this timeframe (epidemiological weeks 8-12, 19-22, and 27-30). The primary outcome was in-hospital mortality. We compared the regional burden of hospital admissions stratified by age, intensive care unit (ICU) admission, and respiratory support. We analysed data from the whole country and its five regions: North, Northeast, Central-West, Southeast, and South.

Findings: Between Feb 16 and Aug 15, 2020, 254 288 patients with RT-qPCR-confirmed COVID-19 were admitted to hospital and registered in SIVEP-Gripe. The mean age of patients was 60 (SD 17) years, 119 657 (47%) of 254 288 were aged younger than 60 years, 143 521 (56%) of 254 243 were male, and 14 979 (16%) of 90 829 had no comorbidities. Case numbers increased across the three 4-week periods studied: by epidemiological weeks 19-22, cases were concentrated in the North, Northeast, and Southeast; by weeks 27-30, cases had spread to the Central-West and South regions. 232 036 (91%) of 254 288 patients had a defined hospital outcome when the data were exported; in-hospital mortality was 38% (87 515 of 232 036 patients) overall, 59% (47 002 of 79 687) among patients admitted to the ICU, and 80% (36 046 of 45 205) among those who were mechanically ventilated. The overall burden of ICU admissions per ICU beds was more pronounced in the North, Southeast, and Northeast, than in the Central-West and South. In the Northeast, 1545 (16%) of 9960 patients received invasive mechanical ventilation outside the ICU compared with 431 (8%) of 5388 in the South. In-hospital mortality among patients younger than 60 years was 31% (4204 of 13 468) in the Northeast versus 15% (1694 of 11 196) in the South.

Interpretation: We observed a widespread distribution of COVID-19 across all regions in Brazil, resulting in a high overall disease burden. In-hospital mortality was high, even in patients younger than 60 years, and worsened by existing regional disparities within the health system. The COVID-19 pandemic highlights the need to improve access to high-quality care for critically ill patients admitted to hospital with COVID-19, particularly in LMICs.

Funding: National Council for Scientific and Technological Development (CNPq), Coordinating Agency for Advanced Training of Graduate Personnel (CAPES), Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ), and Instituto de Salud Carlos III.

Copyright © 2021 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
Study profile SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.
Figure 2
Figure 2
Spatial and temporal spread of the COVID-19 pandemic across three 4-week periods in Brazil The maps show municipalities in which confirmed COVID-19 cases, hospital admissions, and in-hospital deaths were reported during three 4-week periods: epidemiological weeks 8–12 (Feb 16 to March 21, 2020), epidemiological weeks 19–22 (May 3 to May 30, 2020), and epidemiological weeks 27–30 (June 28 to July 25, 2020). Inset shows the five macroregions of Brazil: North (green), Northeast (light orange), Central-West (red), Southeast (blue), and South (purple).
Figure 3
Figure 3
In-hospital mortality stratified by age, sex, comorbidities, level of education, self-reported race, ICU admission, and invasive mechanical ventilation for patients with COVID-19 admitted to hospital in Brazil Data are from patients with a defined hospital outcome; proportions of patients were calculated on the basis of complete case data for sex, comorbidities, level of education, self-reported race, ICU admission, and invasive ventilation variables. Data on race were collected as self-reported race or skin colour, classified as Branco (White), Preto (Black), Pardo (Brown), Amarelo (Asian), or Indígena (Indigenous). ICU=intensive care unit.
Figure 4
Figure 4
Temporal increase in COVID-19 hospital admission rates per 100 000 adult population and crude in-hospital mortality in the five macroregions of Brazil The x-axis denotes the epidemiological week when symptom onset occurred. Shaded areas on the right panel correspond to the upper and lower 95% CIs for in-hospital mortality, estimated by the Agresti-Coull method.
Figure 5
Figure 5
Health-system burden and in-hospital mortality stratified by age in patients with COVID-19 admitted to hospital in the five macroregions of Brazil Burden is defined as the rate of hospital admissions per 100 000 population of each region (top row), and in-hospital mortality as the proportion of patients who died in hospital (bottom row). Data are from patients with a defined hospital outcome and proportions were calculated on the basis of complete case data for ICU admissions and patients receiving invasive mechanical ventilation. ICU=intensive care unit.

References

    1. Amaral PV, Rocha TAH, Barbosa ACQ, Lein A, Vissoci JRN. Spatially balanced provision of health equipment: a cross-sectional study oriented to the identification of challenges to access promotion. Int J Equity Health. 2017;16:209.
    1. Marinho F, de Azeredo Passos VM, Carvalho Malta D, et al. Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392:760–775.
    1. Szwarcwald CL, Souza PR, Júnior, Marques AP, Almeida WD, Montilla DE. Inequalities in healthy life expectancy by Brazilian geographic regions: findings from the National Health Survey, 2013. Int J Equity Health. 2016;15:141.
    1. Candido DS, Claro IM, de Jesus JG, et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020;369:1255–1260.
    1. Massuda A, Hone T, Leles FAG, de Castro MC, Atun R. The Brazilian health system at crossroads: progress, crisis and resilience. BMJ Glob Health. 2018;3
    1. Ali MS, Ichihara MY, Lopes LC, et al. Administrative data linkage in Brazil: potentials for health technology assessment. Front Pharmacol. 2019;10:984.
    1. DATASUS. Ministry of Health SRAG 2020—severe acute respiratory syndrome database—including data from COVID-19. Surveillance of severe acute respiratory syndrome (SARS) July 22, 2020.
    1. Bastos LS, Niquini RP, Lana RM, et al. COVID-19 and hospitalizations for SARI in Brazil: a comparison up to the 12th epidemiological week of 2020. Cad Saude Publica. 2020;36
    1. Xavier DR, Oliveira RAD, Barcellos C, et al. Health regions in Brazil based on hospital admissions: a method to support health regionalization. Cad Saude Publica. 2019;35(suppl 2) (in Portugese).
    1. Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369
    1. Grasselli G, Greco M, Zanella A, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180:1345–1355.
    1. Karagiannidis C, Mostert C, Hentschker C, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8:853–862.
    1. MRC Centre for Global Infectious Disease Analysis. Imperial College London Future scenarios of the healthcare burden of COVID-19 in low- or middle-income countries. COVID-19 LMIC Reports. 2020.
    1. Jalili M, Payandemehr P, Saghaei A, Sari HN, Safikhani H, Kolivand P. Characteristics and mortality of hospitalized patients with COVID-19 in Iran: a national retrospective cohort study. Ann Intern Med. 2020 doi: 10.7326/M20-2911. published online July 20.
    1. Ñamendys-Silva SA, Gutiérrez-Villaseñor A, Romero-González JP. Hospital mortality in mechanically ventilated COVID-19 patients in Mexico. Intensive Care Med. 2020;46:2086–2088.
    1. Orellana JDY, Cunha GMD, Marrero L, Horta BL, Leite IDC. Explosion in mortality in the Amazonian epicenter of the COVID-19 epidemic 19. Cad Saude Publica. 2020;36
    1. Lemos DRQ, D'Angelo SM, Farias LABG, et al. Health system collapse 45 days after the detection of COVID-19 in Ceará, Northeast Brazil: a preliminary analysis. Rev Soc Bras Med Trop. 2020;53
    1. Freitas ARR, Medeiros NM, Frutuoso LCV, et al. Tracking excess deaths associated with the COVID-19 epidemic as an epidemiological surveillance strategy-preliminary results of the evaluation of six Brazilian capitals. Rev Soc Bras Med Trop. 2020;53
    1. Austin S, Murthy S, Wunsch H, et al. Access to urban acute care services in high- vs. middle-income countries: an analysis of seven cities. Intensive Care Med. 2014;40:342–352.
    1. Salluh JIF, Lisboa T. Critical care in Brazil. 2016.
    1. Machado FR, Cavalcanti AB, Bozza FA, et al. The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study. Lancet Infect Dis. 2017;17:1180–1189.
    1. Azevedo LC, Park M, Salluh JI, et al. Clinical outcomes of patients requiring ventilatory support in Brazilian intensive care units: a multicenter, prospective, cohort study. Crit Care. 2013;17:R63.
    1. Hallal PC, Hartwig FP, Horta BL, et al. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys. Lancet Glob Health. 2020;8:e1390–e1398.
    1. Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey. Crit Care. 2020;24:516.
    1. Espinoza R, Silva JRLE, Bergmann A, et al. Factors associated with mortality in severe community-acquired pneumonia: a multicenter cohort study. J Crit Care. 2019;50:82–86.
    1. Nassar AP, Jr, Zampieri FG, Salluh JI, et al. Organizational factors associated with target sedation on the first 48 h of mechanical ventilation: an analysis of checklist-ICU database. Crit Care. 2019;23:34.
    1. Midega TD, Bozza FA, Machado FR, et al. Organizational factors associated with adherence to low tidal volume ventilation: a secondary analysis of the CHECKLIST-ICU database. Ann Intensive Care. 2020;10:68.
    1. Soares M, Bozza FA, Angus DC, et al. Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study. Intensive Care Med. 2015;41:2149–2160.
    1. Bastos LSL, Hamacher S, Zampieri FG, Cavalcanti AB, Salluh JIF, Bozza FA. Structure and process associated with the efficiency of intensive care units in low-resource settings: an analysis of the CHECKLIST-ICU trial database. J Crit Care. 2020;59:118–123.
    1. Sonenthal PD, Masiye J, Kasomekera N, et al. COVID-19 preparedness in Malawi: a national facility-based critical care assessment. Lancet Glob Health. 2020;8:e890–e892.

Source: PubMed

3
Prenumerera